Assessment and treatment of poor tissue perfusion in the critically ill

advertisement
Assessment and treatment of poor
tissue perfusion in the critically ill
patient.
Kenneth J. Drobatz, DVM, MSCE
Professor, Section of Critical Care
University of Pennsylvania
Outline
‰
Why is tissue perfusion important?
– Define shock
– Consequences of poor tissue perfusion(shock)
What causes poor tissue perfusion?
‰ Physical assessment of tissue perfusion.
‰ Objective assessment of tissue perfusion.
‰ Therapy of poor tissue perfusion.
‰
– Reperfusion injury
‰
Monitoring of therapy of poor tissue perfusion.
Why is tissue perfusion so
important?
‰ Provides
oxygen to the tissues.
‰ Provides
nutrients to the tissues.
‰ Removes
tissues.
metabolic wastes from the
Shock
‰ Decrease
in effective blood flow and
oxygen delivery to tissues that does not
meet the demand of the issues (Muir
1990).
‰ Delivery
of oxygen does not meet the
oxygen requirements of the tissues.
Na+
Na+
Na+
Na+
ADP
ATP
ADP
ATP
K+
K+
K+
Mitochondria
ATP
K+
TCA
O2
Na+
ATP
K+
ATP
O2
ADP
ATP
TCA
ATP
ATP
ATP
ADP
K+
ATP
Glycolysis
K+
Na+
ATP
Nucleus
ATP
ADP
ATP ADP
K+
ADP
Na+
Na+
K+
ATP
ADP
K+
ATP
ADP
Na+
Na+
ATP
Decreased tissue perfusion………………..Decreased O2……….. Decreased ATP:
H20
H20
Na+
K+
H20
Na+
Na+
H20
K+
K+
K+
Na+
K+
ATP
Na+
K+
H20
Na+
Na+
K+
Nucleus
K+
K+
K+
H20
Na+
Na+
Na+
H20
H20
Decreased Tissue Perfusion
‰ Cell
swelling.
‰ Increased intracellular calcium
‰ Calcium:
– causes membrane damage.
– Mitochondrial injury – release of iron.
– Activates phospholipase A2
• Increased leukotrienes/prostaglandins
‰ Free
radical production
Consequences of Poor Tissue
Oxygen Delivery: Acronymitis
SIRS – Systemic inflammatory response
syndrome.
‰ CARS – Compensatory anti-inflammatory
response syndrome.
‰ MODS – Multiorgan dysfunction syndrome
‰ MOF – Multiorgan failure.
‰
Bone RC. Sir Isaac Newton, sepsis, SIRS and CARS. Critical Care
Medicine. 24(7): 1125-1128. 1996
SIRS
Fever
‰ Hyperglycemia
‰ Leukocytosis with L
shift
‰ Hyperdynamic
cardiovascular state
‰ Generalized
Vasculitis
‰ Peripheral Edema
‰
Tissue Oxygen Delivery
Blood oxygen content
Hb
concentration
Hb/O2
Saturation
Plasma
O2 content
Cardiac Ouput
Heart Rate
Preload
Stroke
Volume
Contractility Afterload
Cardiac Output
Heart Rate
Preload
Stroke Volume
Afterload
Contractility
Classifications of Altered Tissue
Perfusion
Cardiogenic
Hypovolemia
DCM
Severe fluid loss
HCM
Hemorrhage
Endstage MR
Third space fluid
Myocarditis
Conduction disturbance
Distributive
Sepsis
Endotoxemia
Anaphylaxis
Trauma?
Obstructive
Tamponade
PTE
IC Tumors
GDV
Altered tissue
perfusion can be
due to a variety of
causes, but not all
these causes
result in altered
tissue perfusion.
So…..how do we recognize altered
tissue perfusion……………………?
‰Physical
assessment
‰Objective
assessment?
Tissue Perfusion
Physical Assessment
‰ Physical
evaluation:
– mucous membrane color
– capillary refill time
– pulse rate and quality
– cardiac auscultation, rhythm
– rectal temperature
– extremity temperature
Tissue Perfusion
Physical Assessment
‰
Physical examination evidence of
poor/abnormal tissue perfusion:
–
–
–
–
tachycardia/bradycardia/arrhythmia
weak, bounding, irregular pulses
hyperemic, pale mms, gray, cyanotic mm’s
this doesn’t tell us about other areas
Tissue Perfusion
Objective Assessment?
‰
‰
‰
‰
‰
‰
‰
‰
‰
ECG
Arterial blood pressure
measurement
Central venous pressure
Urine output
Pulmonary artery catheter
Lactate concentration
Gastrointestinal pH
Venous oxygen
concentration?
PCV,TS, colloid oncotic
pressure
Tissue Perfusion
Assessment
‰ There
is no single parameter that provides
the overall answer.
‰ Tissue perfusion assessment requires a
combination of clinical signs, physical
parameters, objective parameters and
response to treatment.
‰ If parameters do not agree with
assessment, reassess!
Physical Assessment Tissue Perfusion
MM color, CRT, HR, PQ, Extremity Temp, Rectal Temp, Urine Output
Abnormal Tissue Perfusion
Cardiogenic
Hypovolemia
Distributive/Sepsis
Auscult Heart
Cardiac Abns?
Murmur, Arrhythmia
Consider Cardiogenic
Normal Cardiac
Auscultation?
Consider Distributive/
Sepis
Consider
Hypovolemia
Altered/poor Tissue Perfusion
Determining Initial Therapy at Presentation
2 Questions
‰ What
does the heart sound like?
‰ What
do the lungs sound like?
Altered/poor Tissue Perfusion
Initial Therapy
‰Give
‰Don’t
fluids?
give fluids?
Altered/poor Tissue Perfusion
Initial Therapy
Poor/Altered Tissue Perfusion
Auscult Heart
Abnormal
Normal
Lung Sounds Abnormal?
Don’t give fluids
or caution with
fluids –could be
cardiogenic
cause
Judicious fluid therapy
Exceptions exist as for any algorithm!
Highly
unlikely
cardiogenic
cause –can
give fluids
Hypovolemia/Sepsis
Fluid Bolus
90 ml/kg-Dog
40-60ml/kg-Cat
Hypertonic Saline?
Reassess
Continue Crystalloids?
Reassess Database
Consider Invasive Monitoring
Colloids
Hetastarch
Dextran 70
Positive Inotropes?
Dobutamine
Dopamine
Blood Products
Whole Blood
Packed RBCs
Plasma
Hb Substitutes
Pressor Agents?
Dopamine
Epinephrine
Norepinephrine
Phenylephrine
Vasopressin
Fluids/Sympathomimetic Drug Doses
‰
‰
Crystalloids (D:90ml/kg, C:
‰
40-60ml/kg)
‰
Synthetic Colloid (D:5ml/kg
boluses not over 20ml/kg/day,C:2
– 5 ml/kg boluses)
‰
Oxyglobin (10 – 30 ml/kg, don’t
exceed 10ml/kg/h)
‰
15ug/kg/min, C: 2.5-5
ug/kg/min
‰
‰
‰
Whole blood 20 – 30 ml/kg
Packed RBCs 5-15 ml/kg
Epinephrine: 1-10 ug/kg/min
Phenylephrine: 5-20 ug/kg
IV q 10-15 min then 0.1-0.5
ug/kg/min)
7.5% Hypertonic saline 46 ml/kg
‰
Dopamine: 1 – 10 ug/kg/min
Dobutamine: D: 5-
‰
Norepinephrine: 0.52ug/kg/min
‰
Vasopressin: 0.5 – 1
mU/kg/min
Pericardial Effusion: Initial
Approach
Oxygen supplementation by mask
‰ IV catheter place: collect blood for analysis.
‰ Fluid Therapy?
‰ Place ECG
‰ Rapid echocardiography if possible
‰ Thoracic radiographs
‰ Pericardiocentesis
‰
Pericardiocentesis:
Equipment
‰
‰
‰
‰
‰
‰
‰
14 – 16 gauge over the
needle catheter
No. 11 scalpel blade
Side holes
20 cc syringe
IV extension tubing
Three-way stopcock
Red top tube and purple
top tube to for
clinicopathologic
evaluation
Pericardiocentesis: Preparation
‰
‰
‰
‰
‰
‰
‰
Right side vs left side
Lateral recumbency vs
sternal
Sterile Preparation
Sedation vs no sedation
Location: usually
between 4th and 6th ribs
at the costochondral
junction.
Local lidocaine block
Skin relief incision
Pericardiocentesis:
Preparation
‰
‰
‰
‰
‰
‰
‰
Right side vs left side
Lateral recumbency vs
sternal
Sterile Preparation
Sedation vs no sedation
Location: usually
between 4th and 6th ribs
at the costochondral
junction.
Local lidocaine block
Skin relief incision
Pericardiocentesis:
Preparation
‰
‰
‰
‰
‰
‰
‰
Right side vs left side
Lateral recumbency vs
sternal
Sterile Preparation
Sedation vs no sedation
Location: usually
between 4th and 6th ribs
at the costochondral
junction.
Local lidocaine block
Skin relief incision
Pericardiocentesis:
Preparation
‰
‰
‰
‰
‰
‰
‰
Right side vs left side
Lateral recumbency vs
sternal
Sterile Preparation
Sedation vs no sedation
Location: usually
between 4th and 6th ribs
at the costochondral
junction.
Local lidocaine block
Skin relief incision
Pericardiocentesis: Procedure
Pericardiocentesis: Procedure
Pericardiocentesis: Post Tap
Reperfusion Injury
Altered perfusion,
“no-reflow”
‰ Toxic oxygen radical
production.
‰ Further membrane
damage.
‰ Hyperkalemia
‰ Hyperlactatemia
‰
Reperfusion Injury
Clinically Unproven Drugs
‰
Allopurinol (Burroughs Welcome, 30 mg/kg divided q 8 – 12 hours).
‰
Mannitol 20% (Baxter), 0.5-2 g/kg IV slowly
‰
DMSO,(Syntex Animal Health), 1 g/kg IV over 45 minutes
‰
Deferoxamine mesylate (CIBA), 5-15 mg/kg IV during CPR, 50
mg/kg IV over 5 minutes to prevent reperfusion injury in dogs with GDV)
Altered Tissue Perfusion
Monitoring Response To Therapy
‰
Monitor response to
therapy:
– Physical parameters
– ECG
– Arterial blood pressure
measurement
– Central venous pressure
– Urine output
– Pulmonary artery catheter
– Lactate concentration
– Gastointestinal pH
– Venous oxygen
concentration?
– PCV,TS, colloid oncotic
pressure
Altered Tissue Perfusion
Monitoring Response To Therapy
Renal failure
‰ Gastrointestinal
compromise
‰
– Bacterial translocation
ARDS
‰ Disseminated
intravascular
coagulation
‰ Brain dysfunction
‰ Nutrition?
‰
Altered Tissue Perfusion
Other Thoughts
‰
Corticosteroids for Shock
– Highly Controversial
– Reported Experimental Benefits(very high dose)
•
•
•
•
•
Antiinflammatory
Improve membrane stability
Improved microcirculation
Improved intermediary metabolism
Improved survival in some studies
– Results of clinical studies conflicting
– “Shock is a complex disease and, consequently the
efficacy of such treatments such as corticosteroids is
a complex question whose answer is not yet known”
Haskins 2005
Altered Tissue Perfusion
Other Thoughts
‰ Low
dose corticorticosteroids in refractory
hypotensive septic shock:
– Recent evidence is accumulating that people
with septic shock have relative adrenal
insufficiency.
– Lower dose corticosteroids may be beneficial
in people with septic shock.
– Human and veterinary clinical studies are
ongoing.
Altered Tissue Perfusion
Other Thoughts
‰ Doses
¾
¾
¾
¾
used in people:
Hydrocortisone 100 mg TID X 5 days.
Hydrocortisone 100 mg, followed by CRI if
0.18mg/kg/h X 6 days.
Hydrocortisone 50 mg q6hrs X 7 days.
Prednisolone 5 mg @ 6am and 2.5 mg @ 6pm X
10 days.
Altered Tissue Perfusion
Other Thoughts
‰ Delayed
hypotensive resuscitation
– Used in acute and ongoing abdominal
hemorrhage
– Resuscitate to a minimally acceptable blood
pressure.
– Surgical correction of hemorrhage and then
“normal” resuscitation.
– More studies needed
– Applicable to veterinary medicine?
Altered Tissue Perfusion
Summary
History and physical parameters give the most
rapid and encompassing information regarding
the presence of altered tissue perfusion and it’s
underlying cause.
‰ Early and aggressive resuscitation (fluids,
colloids, blood products, sympathomimetics).
‰ Monitor response to therapy and adjust
accordingly.
‰ Identify underlying cause rapidly and treat.
‰ Monitor of consequences of severe altered
tissue perfusion.
‰
Questions?
Download